GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?

26 Sep 2005

• By The Pink Sheet

GlaxoSmithKline plans to end 2006 with six product launches and six regulatory filings, CEO J.P. Garnier said during a presentation at the Bear Stearns Healthcare conference in New York Sept. 13

GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?

More from Archive

More from Pink Sheet